170 related articles for article (PubMed ID: 22425908)
1. Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.
Duncavage EJ; Abel HJ; Szankasi P; Kelley TW; Pfeifer JD
Mod Pathol; 2012 Jun; 25(6):795-804. PubMed ID: 22425908
[TBL] [Abstract][Full Text] [Related]
2. Genetic Screening Test to Detect Translocations in Acute Leukemias by Use of Targeted Locus Amplification.
Alimohamed MZ; Johansson LF; de Boer EN; Splinter E; Klous P; Yilmaz M; Bosga A; van Min M; Mulder AB; Vellenga E; Sinke RJ; Sijmons RH; van den Berg E; Sikkema-Raddatz B
Clin Chem; 2018 Jul; 64(7):1096-1103. PubMed ID: 29794109
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.
Yao H; Wu C; Chen Y; Guo L; Chen W; Pan Y; Fu X; Wang G; Ding Y
Mol Genet Genomic Med; 2020 Sep; 8(9):e1369. PubMed ID: 32638549
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
[TBL] [Abstract][Full Text] [Related]
7. The added values of multiplex reverse transcriptase-PCR followed by mutation screening in the initial evaluation of acute leukemia.
Kim B; Cho YU; Bae MH; Jang S; Seo EJ; Chi HS; Park CJ
Int J Lab Hematol; 2016 Aug; 38(4):444-53. PubMed ID: 27321126
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
10. Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.
Salipante SJ; Fromm JR; Shendure J; Wood BL; Wu D
Mod Pathol; 2014 Nov; 27(11):1438-46. PubMed ID: 24743218
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
[TBL] [Abstract][Full Text] [Related]
12. [C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].
Ding ZX; Shen HJ; Miao JC; Chen SN; Qiu QC; Qi XF; Jin ZM; Wu DP; He J
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):829-34. PubMed ID: 23384905
[TBL] [Abstract][Full Text] [Related]
13. Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes.
Izevbaye I; Liang LY; Mather C; El-Hallani S; Maglantay R; Saini L
J Mol Diagn; 2020 Feb; 22(2):208-219. PubMed ID: 31751678
[TBL] [Abstract][Full Text] [Related]
14. Identifying large indels in targeted next generation sequencing assays for myeloid neoplasms: a cautionary tale of the
Ng IK; Ng C; Low JJ; Chiu L; Seah E; Ng CH; Chng WJ; Yan B; Ban KHK
J Clin Pathol; 2017 Dec; 70(12):1069-1073. PubMed ID: 28676493
[TBL] [Abstract][Full Text] [Related]
15. Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring.
Crowgey EL; Mahajan N; Wong WH; Gopalakrishnapillai A; Barwe SP; Kolb EA; Druley TE
BMC Med Genomics; 2020 Mar; 13(1):32. PubMed ID: 32131829
[TBL] [Abstract][Full Text] [Related]
16. [Association of Next Generation Sequencing Based Genotypic Profiling with MICM Characteristics in NPM1 Mutated Acute Myeloid Leukemia].
Wang B; Ling Y; Dai L; Gu WY; Zhang XW; Xing SS; Li HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):56-60. PubMed ID: 35123604
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
[TBL] [Abstract][Full Text] [Related]
18. Next-generation carrier screening.
Umbarger MA; Kennedy CJ; Saunders P; Breton B; Chennagiri N; Emhoff J; Greger V; Hallam S; Maganzini D; Micale C; Nizzari MM; Towne CF; Church GM; Porreca GJ
Genet Med; 2014 Feb; 16(2):132-40. PubMed ID: 23765052
[TBL] [Abstract][Full Text] [Related]
19. A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients.
Prieto-Conde MI; Corchete LA; García-Álvarez M; Jiménez C; Medina A; Balanzategui A; Hernández-Ruano M; Maldonado R; Sarasquete ME; Alcoceba M; Puig N; González-Calle V; García-Sanz R; Gutiérrez NC; González-Díaz M; Chillón MC
J Mol Diagn; 2020 Jan; 22(1):60-71. PubMed ID: 31605801
[TBL] [Abstract][Full Text] [Related]
20. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
